Intelligent Bio Solutions completes drug screening clinical study

Go back to Intelligent Bio Solutions completes drug screening clinical study
(NASDAQ: INBS) Delayed: 2.15 -0.08 (3.59%)
Previous Close $2.23    52 Week High
Open $2.25    52 Week Low
Day High $2.29    P/E N/A 
Day Low $2.13    EPS
Volume 69,688